These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38989579)

  • 21. Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis.
    Boumaza A; Gay L; Mezouar S; Bestion E; Diallo AB; Michel M; Desnues B; Raoult D; La Scola B; Halfon P; Vitte J; Olive D; Mege JL
    J Infect Dis; 2021 Aug; 224(3):395-406. PubMed ID: 33493287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monocyte-Mediated Thrombosis Linked to Circulating Tissue Factor and Immune Paralysis in COVID-19.
    Goonewardena SN; Chen Q; Tate AM; Grushko OG; Damodaran D; Blakely PK; Hayek SS; Pinsky DJ; Rosenson RS
    Arterioscler Thromb Vasc Biol; 2024 May; 44(5):1124-1134. PubMed ID: 38511328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients.
    Hammoudeh SM; Hammoudeh AM; Bhamidimarri PM; Al Safar H; Mahboub B; Künstner A; Busch H; Halwani R; Hamid Q; Rahmani M; Hamoudi R
    Front Immunol; 2021; 12():595150. PubMed ID: 34262555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases.
    Carsetti R; Zaffina S; Piano Mortari E; Terreri S; Corrente F; Capponi C; Palomba P; Mirabella M; Cascioli S; Palange P; Cuccaro I; Milito C; Zumla A; Maeurer M; Camisa V; Vinci MR; Santoro A; Cimini E; Marchioni L; Nicastri E; Palmieri F; Agrati C; Ippolito G; Porzio O; Concato C; Onetti Muda A; Raponi M; Quintarelli C; Quinti I; Locatelli F
    Front Immunol; 2020; 11():610300. PubMed ID: 33391280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19.
    Bergantini L; d'Alessandro M; Cameli P; Cavallaro D; Gangi S; Cekorja B; Sestini P; Bargagli E
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced monocyte proportions and responsiveness in convalescent COVID-19 patients.
    Ravkov EV; Williams ESCP; Elgort M; Barker AP; Planelles V; Spivak AM; Delgado JC; Lin L; Hanley TM
    Front Immunol; 2023; 14():1329026. PubMed ID: 38250080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of natural killer markers associated with fatal outcome in COVID-19 patients.
    Tarantino N; Litvinova E; Samri A; Soulié C; Morin V; Rousseau A; Dorgham K; Parizot C; Bonduelle O; Beurton A; Miyara M; Ghillani P; Mayaux J; Lhote R; Lacorte JM; Marcelin AG; Amoura Z; Luyt CE; Gorochov G; Guihot A; Vieillard V
    Front Cell Infect Microbiol; 2023; 13():1165756. PubMed ID: 37342247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Granulocytic Signature Identifies COVID-19 and Its Severity.
    Vitte J; Diallo AB; Boumaza A; Lopez A; Michel M; Allardet-Servent J; Mezouar S; Sereme Y; Busnel JM; Miloud T; Malergue F; Morange PE; Halfon P; Olive D; Leone M; Mege JL
    J Infect Dis; 2020 Nov; 222(12):1985-1996. PubMed ID: 32941618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.
    Chen H; Liu W; Wang Y; Liu D; Zhao L; Yu J
    EBioMedicine; 2021 Aug; 70():103500. PubMed ID: 34311326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The longitudinal characterization of immune responses in COVID-19 patients reveals novel prognostic signatures for disease severity, patients' survival and long COVID.
    Noviello M; De Lorenzo R; Chimienti R; Maugeri N; De Lalla C; Siracusano G; Lorè NI; Rancoita PMV; Cugnata F; Tassi E; Dispinseri S; Abbati D; Beretta V; Ruggiero E; Manfredi F; Merolla A; Cantarelli E; Tresoldi C; Pastori C; Caccia R; Sironi F; Marzinotto I; Saliu F; Ghezzi S; Lampasona V; Vicenzi E; Cinque P; Manfredi AA; Scarlatti G; Dellabona P; Lopalco L; Di Serio C; Malnati M; Ciceri F; Rovere-Querini P; Bonini C
    Front Immunol; 2024; 15():1381091. PubMed ID: 39136010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease-duration based comparison of subsets of immune cells in SARS CoV-2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity.
    Kulkarni-Munje A; Palkar S; Shrivastava S; Lalwani S; Mishra AC; Arankalle VA
    Immun Inflamm Dis; 2021 Jun; 9(2):419-434. PubMed ID: 33452858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated circulating monocytes and monocyte activation in COVID-19 convalescent individuals.
    Park J; Dean LS; Jiyarom B; Gangcuangco LM; Shah P; Awamura T; Ching LL; Nerurkar VR; Chow DC; Igno F; Shikuma CM; Devendra G
    Front Immunol; 2023; 14():1151780. PubMed ID: 37077911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monocytes and the 38kDa-antigen of mycobacterium tuberculosis modulate natural killer cell activity and their cytolysis directed against ovarian cancer cell lines.
    Gottschalk N; Lang S; Kimmig R; Singh M; Brandau S
    BMC Cancer; 2012 Oct; 12():451. PubMed ID: 23036052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NK cell receptor and ligand composition influences the clearance of SARS-CoV-2.
    Hsieh WC; Lai EY; Liu YT; Wang YF; Tzeng YS; Cui L; Lai YJ; Huang HC; Huang JH; Ni HC; Tsai DY; Liang JJ; Liao CC; Lu YT; Jiang L; Liu MT; Wang JT; Chang SY; Chen CY; Tsai HC; Chang YM; Wernig G; Li CW; Lin KI; Lin YL; Tsai HK; Huang YT; Chen SY
    J Clin Invest; 2021 Nov; 131(21):. PubMed ID: 34720095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computational identification of mitochondrial dysfunction biomarkers in severe SARS-CoV-2 infection: Facilitating therapeutic applications of phytomedicine.
    Zhang L; Li Y; Hu W; Gao S; Tang Y; Sun L; Jiang N; Xiao Z; Han L; Zhou W
    Phytomedicine; 2024 Aug; 131():155784. PubMed ID: 38878325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma Extracellular Vesicles Derived from Pediatric COVID-19 Patients Modulate Monocyte and T Cell Immune Responses Based on Disease Severity.
    Cetinkaya PG; Abras IF; Evcili I; Yildirim T; Ceylan Y; Kara Eroglu F; Kayaoglu B; İpekoglu EM; Akarsu A; Yıldırım M; Kahraman T; Cengiz AB; Sahiner UM; Sekerel BE; Ozsurekci Y; Soyer O; Gursel I
    Immunol Invest; 2024 Oct; 53(7):1141-1175. PubMed ID: 39115924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Characterization of Monocyte Subsets Reveals Specific and Distinctive Molecular Signatures Associated With Cardiovascular Disease in Rheumatoid Arthritis.
    Ruiz-Limon P; Ortega-Castro R; Barbarroja N; Perez-Sanchez C; Jamin C; Patiño-Trives AM; Luque-Tevar M; Ibáñez-Costa A; Perez-Sanchez L; de la Rosa IA; Abalos-Aguilera M; Jimenez-Gomez Y; Calvo-Gutierrez J; Font P; Escudero-Contreras A; Alarcon-Riquelme ME; Collantes-Estevez E; López-Pedrera C;
    Front Immunol; 2019; 10():1111. PubMed ID: 31169830
    [No Abstract]   [Full Text] [Related]  

  • 38. Compartmentalization of innate immune responses in the central nervous system during cryptococcal meningitis/HIV coinfection.
    Naranbhai V; Chang CC; Durgiah R; Omarjee S; Lim A; Moosa MY; Elliot JH; Ndung'u T; Lewin SR; French MA; Carr WH
    AIDS; 2014 Mar; 28(5):657-66. PubMed ID: 24451162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of SARS-CoV-2-specific immune alterations in acutely ill patients.
    Rébillard RM; Charabati M; Grasmuck C; Filali-Mouhim A; Tastet O; Brassard N; Daigneault A; Bourbonnière L; Anand SP; Balthazard R; Beaudoin-Bussières G; Gasser R; Benlarbi M; Moratalla AC; Solorio YC; Boutin M; Farzam-Kia N; Descôteaux-Dinelle J; Fournier AP; Gowing E; Laumaea A; Jamann H; Lahav B; Goyette G; Lemaître F; Mamane VH; Prévost J; Richard J; Thai K; Cailhier JF; Chomont N; Finzi A; Chassé M; Durand M; Arbour N; Kaufmann DE; Prat A; Larochelle C
    J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33635833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome.
    Huang JJ; Gaines SB; Amezcua ML; Lubell TR; Dayan PS; Dale M; Boneparth AD; Hicar MD; Winchester R; Gorelik M
    J Allergy Clin Immunol; 2022 Mar; 149(3):912-922. PubMed ID: 34688775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.